Canine Hereditary Cancer Consortium (CHCC) - The CHCC is studying canine melanoma and are requesting blood samples from any purebred dog to further their research to identify the underlying genetic lesions and biochemical pathways that contribute to this disease.
Cornell University College of Veterinary Medicine - cancer research
Gulf Coast Veterinary Specialists - oncology
Oncolink - Abramsom Cancer Center of the University of Pennsylvania
Veterinary Cancer Society - a non-profit educational organization formed in 1874 by a group of veterinary oncologists
AKC CHF - Osteosarcoma Report and Call for More Samples
[Tuesday, August 10, 2010]
Osteosarcoma (OSA) is the most common malignant bone cancer in dogs and is an important health concern, accounting for five to six percent of all canine cancers. In the United States, 8,000 – 10,000 cases are reported annually. It is a very aggressive cancer and in the majority of cases, metastasis and death follow within a few months or years. The median survival time for dogs treated with amputation plus chemotherapy is 12 months, with only 20% surviving two years.
While osteosarcoma can occur in dogs of any size, some large and giant dog breeds have a much higher risk of developing OSA within their lifetime than other breeds (three to fifteen fold increased risk compared to the average in dogs) including the long-limbed hounds (Greyhounds, Irish Wolfhounds, Great Danes, Scottish Deerhounds, Rhodesian Ridgebacks, Great Pyrenees and Borzoi) and Mastiff-type breeds (Rottweiler, Labrador Retriever, Flat-Coated Retriever, Golden Retriever, Mastiff, Bullmastiff, Saint Bernard, Irish Setter and Newfoundland). The average age at diagnosis is seven to eight years old.
Studying heart function in dogs with lymphoma -- All Breeds
A new Veterinary Teaching Hospital study is being conducted to
determine whether doxorubicin, one of the primary drugs used in
treating lymphoma in dogs, may weaken the canine heart.
Please e-mail firstname.lastname@example.org for more information.
Dogs with Oral Melanoma -- All Breeds
Dogs with oral melanoma are being recruited for a study of a novel
vaccine developed by Merial Limited, an animal pharmaceutical
company, to determine if this vaccine can help to prolong the
survival time in dogs with oral melanoma. Dogs enrolled in the study
will receive the melanoma vaccine and associated exams and labwork
and radiographs which will be subsidized by the study.
For more information on this study email: email@example.com or
firstname.lastname@example.org or call 919-513-6812.